Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Immunoglobulins are members of the glycoprotein superfamily that play a central role in the adaptive immune response.1 They are produced by B cells and later secreted by plasma cells as antibodies.2 Immunoglobulins are composed of two heavy chains of approximately 50 kDa each and two light chains of approximately 25 kDa each.1 The heavy chains are linked together by disulfide bonds to form an Fc region and also combine with the light chains to form the Fab region, which mediate receptor and antigen binding, respectively.3 Mammalian immunoglobulins contain either Igκ or Igλ light chains, each of which are composed of a constant and variable domain.4 The ratio of Igκ to Igλ light-chain containing antibodies varies between species, with ratios of 20:1, 2:1, and 1:20 in mice, humans, and cattle, respectively. Igκ and Igλ free light chains (FLCs) are produced during immunoglobulin synthesis, and accumulation of these FLCs is associated with various disorders, including light-chain deposition disease, multiple myeloma, rheumatoid arthritis, diabetic nephropathy, and systemic lupus erythematosus (SLE).2,5,6 Cayman's Ig Light Chain (human) Rabbit Monoclonal Antibody (Clone RM129) be used for ELISA, flow cytometry (FC), immunocytochemistry (ICC), and immunohistochemistry (IHC) applications. The antibody recognizes both the Igĸ and Igλ light chains from human samples.
WARNING This product is not for human or veterinary use.
1. Structure and function of immunoglobulins. J. Allergy Clin. Immunol. 125(2 Suppl. 2), S41-S52 (2010).
2. The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases. Biomed. Pharmacother. 91, 632-644 (2017).
3. Immunoglobulin. 2020, (2020).
4. Antigen recognition by B-
5. Light chain deposition disease: Novel biological insights and treatment advances. Int. J. Lab. Hematol. 34(4), 347-355 (2012).
6. IgA kappa light and heavy chain deposition disease in multiple myeloma. Br. J. Haematol. 183(1), 13 (2018).